Close
Digital Health & Ai Innovation summit 2026
LiGHT26

Steps to Take Immediately After a Slip-and-Fall Personal Injury

Nestled in the southeastern region of the United States lies South Carolina, a state rich in history, culture, and natural beauty. Bordered by North Carolina to the north, Georgia to the south and west, and the Atlantic Ocean to the east, South Carolina boasts a diverse landscape ranging from sandy beaches to lush forests and rolling hills. Its strategic location along major transportation routes, including I-95 and I-26, makes it a hub for commerce and travel. However, with bustling roads and heavy traffic, the risk of slip-and-fall accidents resulting in personal injuries is a pressing concern.

Slip-and-fall accidents can happen to anyone, anywhere, and anytime. They can occur in public places like supermarkets, shopping malls, sidewalks, or even at someone’s home. When these accidents result in personal injuries, it’s important to take immediate action to protect your rights and ensure the best possible outcome, something a personal injury attorney in South Carolina can help with. In this article, we will outline the crucial steps to take after a slip-and-fall accident to properly document the incident, seek medical attention, collect evidence, and establish liability.

Seek Medical Attention

The first step after a slip-and-fall accident is to seek medical attention promptly. Even if you don’t think your injuries are severe at first sight, some injuries might not show immediate symptoms or may worsen over time. By seeking professional medical assessment and treatment right away, you not only safeguard your health but also create official documentation of your injuries.

Report the Incident

Next, report the incident to the appropriate authority or property manager. It’s essential to notify them as soon as possible about what happened and where it occurred. Make sure you gather all relevant details, such as the date, time, location of the incident, and any witnesses present at that time.

Document Everything

Documentation is key when pursuing a slip-and-fall personal injury claim. Start by writing down everything that happened leading up to and after the accident while your memory is fresh. Include details like how you fell exactly: was there any wet floor sign? Were there hazardous conditions present? Additionally, take photos of the accident scene from multiple angles, along with any visible signs of neglect or dangerous premises.

Contact Witnesses

If there were any witnesses present during the incident who saw what happened or spoke with you afterward, try obtaining their contact information if possible. Witness statements can be an invaluable source of evidence when establishing liability for a slip-and-fall personal injury case.

Maintain Evidence

Preserve all available physical evidence related to your slip-and-fall accident case. If your clothing got ripped or damaged, keep them aside along with the shoes you were wearing. Also, carefully preserve any receipts related to medical expenses, transportation costs to and from medical appointments, and any other injury-related expenses. These pieces of evidence can strengthen your case when you’re trying to prove negligence or liability.

Do Not Give Statements Without Legal Advice

Once you report the incident to the relevant authority, property manager, or insurance representative, you may be asked for a recorded statement about what happened. Here, it’s important to remember that you have the right to legal representation before providing any statements. It’s highly advisable not to give any oral or written statements without first consulting a personal injury attorney. Even though it might seem harmless at first, your words could be misconstrued or taken out of context later, playing a major role in the outcome of your case.

Consult an Experienced Personal Injury Attorney

To protect your rights and maximize your chances of receiving fair compensation for your slip-and-fall injuries, contacting an experienced personal injury attorney is vital. They can guide you through the legal process, gather evidence on your behalf, negotiate with insurance companies for a fair settlement amount, and even file a lawsuit if necessary.

Statute of Limitations

Keep in mind that there are specific time limits called “statute of limitations” within which you may file a slip-and-fall personal injury claim. These deadlines vary by jurisdiction and depend on various factors such as where the incident occurred and the type of defendant involved (e.g., government entity, private establishment). Therefore, it’s crucial to consult with an attorney as soon as possible so that they can ensure all necessary paperwork is filed within the required time frame.

Conclusion

After experiencing a slip-and-fall accident resulting in personal injury, taking immediate action can make all the difference in protecting your rights. Seek medical attention promptly, report the incident to authorities or property managers, gather evidence, including witness statements if possible, preserve any available physical evidence, and document everything related to your injuries and treatment expenses. Lastly, and perhaps most importantly, consult an experienced personal injury attorney who can provide guidance, negotiate with insurance companies, and advocate for fair compensation on your behalf. By following these steps, you can set yourself up for the best possible outcome in your slip-and-fall personal injury claim.

The Future of Healthcare: Interoperability and the Patient Experience

Fragmentation in healthcare data is a stark reality today. Many patients’ medical records lie dispersed among several filing cabinets, each originating from a separate physician’s office, hospital, or laboratory. Such fragmentation of medical records into discrete systems often breeds challenges for healthcare professionals to fully understand a patient’s condition. This leads to frustration for patients and their families in managing and producing records and may also hurt their care.

In addition to having to repeat tests they’ve already had, patients may find it difficult to coordinate care between specialists and have a vague idea of their overall health status. It is here that the concept of interoperability in healthcare emerges as particularly useful, helping patients and their families navigate complexities easily and dictating the future of patient experience.

The Benefits of Interoperability for Patients

Interoperability can help resolve the disjointed healthcare environment. It refers to the ability of various healthcare information systems to use and exchange data without any hiccups. Here are some of the most prominent benefits of interoperability for patients today:

1 Seamless Access to Medical Records

Imagine a time when seeing a specialist or changing doctors wouldn’t require you to gather previous medical records frantically. This is made possible through interoperability. No matter where it was created, patients can access their medical history by enabling seamless communication between various healthcare systems. This covers prescription lists, imaging scans, lab results, and doctor’s notes.

A safe mobile app or web portal can provide easy access to this data. Because previous results are not accessible to a new provider, this eliminates the frustration of repeating tests. More significantly, patients are empowered to disclose their medical history, enabling them to make educated healthcare decisions with their physicians.

2 Improved Care Coordination

Healthcare providers can communicate and work together more easily when there is interoperability. Medical data can now be shared freely when a patient sees multiple specialists or receives treatment at different facilities. This gives medical professionals a more complete picture of the patient’s health. Better-coordinated care plans result from their ability to view previous diagnoses, treatment regimens, and drug allergies.

As a result, there is a lower chance of taking drugs that conflict with needless procedures. Furthermore, experts can swiftly review a patient’s medical history, enabling them to enhance current treatment plans and prevent delays in initiating new ones. Patients ultimately benefit from a more streamlined and effective healthcare experience due to interoperability.

3 Patient Empowerment

Patients take an active role in their healthcare journey when they have better access to their medical data and care coordination. Patients benefit from interoperability because it gives them ownership of their medical records. During consultations, they can review test results, monitor the course of treatment, and ask well-informed questions.

With this newfound understanding, patients feel more in control and can work with their doctors to make well-informed decisions regarding their care. In addition, the emergence of personal health records (PHRs) and patient portals offers more resources for patient involvement. These platforms increase patient engagement throughout their healthcare process by enabling patients to handle and safely store their medical records.

Technological Advancements and the Future of Interoperability

Standardized Data Formats: By serving as a common language, standardized data formats guarantee that all healthcare information is presented uniformly. This enables various systems to interpret data accurately, promoting efficient communication. FHIR (Fast Healthcare Interoperability Resources) is one possible remedy. A new standard called FHIR is gaining popularity in the healthcare sector. It employs an adaptable and user-friendly format that works with different kinds of medical data. Healthcare systems can overcome compatibility problems and achieve interoperability by implementing standardized formats like FHIR.

Cloud-based Solutions and APIs: Leveraging the power of cloud computing and application programming interfaces (APIs) is key to the future of interoperability. Authorized providers can access a central repository for patient data through cloud storage from any location with an internet connection. This promotes real-time data sharing and eliminates the need for physical data exchange between systems. APIs are messengers that facilitate safe data exchange and communication between various healthcare systems. An API allows a provider to retrieve patient data from another system easily. Cloud-based solutions have a lot to offer. Because of their high scalability, they can change to handle increasing data volumes. Furthermore, authorized users can access cloud storage more easily from anywhere.

Emerging Technologies: The state of interoperability is continuously changing as new technologies are developed to improve data exchange even more. Healthcare data analysis could be revolutionized by artificial intelligence (AI). Large volumes of medical data can be analyzed by AI algorithms, which can spot patterns and trends that humans might overlook. This may result in more precise diagnoses, individualized treatment programs, and a better comprehension of how diseases progress. Blockchain technology also provides a safe and impenetrable way to handle and store medical data. Because blockchain operates on a decentralized network, it is extremely resilient to data breaches and cyberattacks. The future of interoperability promises even greater efficiency, accuracy, and security in exchanging healthcare data by utilizing these cutting-edge technologies.

Interoperability Challenges to Consider

Although interoperability has many advantages, privacy and data security issues are also discussed. Protecting sensitive patient data becomes more important as data sharing increases. Strong security protocols are necessary to prevent unwanted access and data breaches. Data can be encrypted and rendered unreadable, protecting it from interception even if intercepted. Furthermore, access controls specify who is allowed access to particular data and for what purposes. This guarantees that patients’ medical records are only accessible to authorized personnel.

Unambiguous rules and standards are necessary to achieve broad interoperability. Healthcare organizations might be reluctant to embrace new technologies or data formats without a clear framework. Standardized regulations ensure consistency and compatibility across the healthcare ecosystem. This makes it possible to take a more unified approach to data exchange, which promotes smooth provider collaboration and communication.

Switching to a completely interoperable healthcare system will cost much money. Financial difficulties may arise for healthcare organizations when introducing new technology, modernizing outdated systems, and guaranteeing adherence to new rules. But in the long run, the advantages outweigh the disadvantages. Interoperability lowers healthcare costs by increasing efficiency, reducing redundancy, and improving patient outcomes.

Conclusion

The future of healthcare is incredibly promising when it comes to interoperability. It encourages more coordinated care plans, gives patients more control over their health, and improves patient outcomes by facilitating smooth data exchange between providers.

Standardized data formats, cloud-based services, and cutting-edge technologies like blockchain and artificial intelligence will further improve future interoperability. Although there are still difficulties with maintaining data security, getting around regulatory restrictions, and controlling implementation costs, these difficulties are outweighed in the long run.

We can anticipate when patients are at the center of their care and have easy access to all the healthcare data they need to make educated decisions and maximize their health journey as we transition to a more integrated and interoperable healthcare system.

LiveData PeriOp Tools Recognized as a Top Hospital IT Solution for 2024

LiveData PeriOp Tools Recognized as a Top Hospital IT Solution for 2024

LiveData, a surgical capacity optimization solution company announced that it was named a Top Hospital IT Solution by Black Book Research, the premier source of unbiased, crowdsourced, competitive intelligence and IT buyer opinion mining serving the healthcare delivery sectors. The 2024 awards are based on the responses to the Inpatient Clinical IT User Survey. This year, Black Book received 14,144 validated surveys dedicated to identifying the best possible hospital user experience and highest clinician satisfaction. LiveData was recognized in the Inpatient Surgical and Perioperative Solutions category.

“We are delighted to be recognized as a Top Hospital IT Solution for 2024, especially given that the award is based solely on user feedback,” said LiveData CEO Jeff Robbins. “LiveData PeriOp Manager™ and LiveData Procedure Suite Manager™ were created to optimize capacity to reduce the strain on staff while enabling facilities to deliver superior care to as many patients as possible. This award underscores that our customers not only find our products useful but that the experience they deliver makes a difference in their day-to-day operations.”

LiveData PeriOp Manager enables hospital teams to optimize surgical capacity by streamlining processes, increasing OR utilization, reducing delays and cancellations, mitigating the impact of staff shortages, improving inter-departmental communications, enhancing patient safety, and increasing case volume. It integrates with electronic health records (EHRs) and hospital information systems to automate and optimize perioperative workflows.

Recently introduced, LiveData Procedure Suite Manager applies the same capacity optimization strategies to procedure rooms. Procedure Suite Manager optimizes these crucial spaces, minimizing operational challenges and maximizing patient care. By elevating the performance of procedure rooms, hospitals can enhance overall efficiency, raise the standard of patient care, and better serve their patients. Both solutions grant clinic schedulers curated access to the hospital’s surgical and procedural calendars, which is not typically available to surgeon offices. From the clinic office, schedulers can confidently find and reserve open slots in real time. Hospital schedulers retain the final authority to approve case requests. Both PeriOp Manager and Procedure Suite Manager share scheduling data with the EHR and other LiveData solution modules.

The Black Book™ founder, management, and employees have no financial stake in the companies featured in any comparison performance report. They are not motivated by incentives to recommend any of the 20,000 healthcare industry products and services vendors collected over the last decade.

Research In Neuroblastoma May Lead To Improved Estimates

One of the new neuroblastoma studies has gone on to identify the new subgroups having distinct prognoses as well as vulnerabilities to therapies.

Researchers have gone on to identify new variations when it comes to neuroblastoma that could go on to lead to a more precise prognosis as well as better-targeted treatments.

The study has gone on to reveal the three new subgroups of the most common kinds of neuroblastoma, each having varied genetic traits, anticipated outcomes, and distinguishing traits that go on to offer insights into the most effective treatments.

The University of Southampton’s Dr. Yihua Wang, who is a senior author on the paper, opined that this research goes on to represent a pivotal advancement in their understanding of MYCN non-amplified neuroblastomas, and the fact is that the results happen to be striking.

Such types of neuroblastomas can be classified into three unique subgroups, each giving out a unique prognostic implication as well as varying vulnerabilities pertaining to investigational therapies.

Neuroblastoma: An Introduction

Almost 100 children happen to be diagnosed with neuroblastoma every year in the UK.

It happens to be a type of cancer that begins in a type of nerve cell named a neuroblast.

Neuroblastoma can go on to be present in the abdomen, chest, neck, or even the pelvis region and can, as a matter of fact, spread across other parts of the body.

The entire prognosis of the disease happens to be quite poor, with 20% of the patients still alive five years after the diagnosis.

The fact is that the likelihood of cancer being cured varies quite broadly, as some tumors spontaneously regress while there are others are resistant to therapy.

One of the major indicators of the risk is the amplification of a gene named MYCN, where tumors happen to be having too many of this type of gene.

This happens to be in around 20% of the cases and accounts for almost 40% of the high-risk neuroblastomas.

Rising understanding of diversity of outcomes

The University of Southampton team and China wanted to pry out more pertaining to the cases where the MYCN gene is not amplified to comprehend the diversity when it comes to the outcomes within such cases.

The team made use of advanced analytical techniques in order to analyze more than 1,500 biopsy samples across 16 different datasets, which were sourced from Gene Expression Omnibus as well as ArrayExpress.

Due to this, they went ahead and identified three distinct subtypes of such kind of MYCN non-amplified cases based on their transcriptional signatures.

Subgroups

Apparently, the first subgroup comprises almost half of MYCN non-amplified cases and happens to have the best prognosis. This group had a long-term survival rate of more than 85%, in spite of some cases being clinically classified as high-risk.

Subgroup 2 comprised a quarter of cases sans the MYCN amplification, and exhibited the poorest outcomes, having a long-term survival rate of 50%. Interestingly, such a subgroup shared a genetic profile that was akin to the cases having MYCN amplification.

It is worth noting that the researchers identified enhanced expression levels of the Aurora Kinase A- AURKA protein, which are prominently higher as compared to other subgroups. Subsequent examinations went on to reveal that AURKA mRNA levels alone can very well serve as a predictor of complete survival, which itself kind of suggests potential benefits pertaining to AURKA inhibitor treatment for the patients within this subgroup.

In contrast, the Subgroup 3, that went on to constitute yet another quarter of MYCN non-amplified cases, displayed an inflamed gene signature which gets characterized by heightened activity within the immune cells.

More analysis on this suggests that patients in this subgroup may go on to exhibit elevated responsiveness to the immunotherapy.

A new alternative for neuroblastoma treatment

Dr.Wang went on to conclude that the research opens new kinds of avenues for personalized medicine when it comes to the treatment of neuroblastomas.

Through leveraging transcriptional subtyping, they happen to be now equipped to go ahead and provide more precise prognosis as well as customized therapies according to patients having MYCN non-amplified neuroblastomas, thereby in a way improving outcomes as well as the quality of life.

Optimizing Breast Cancer Risk-Screening With A Dual AI Model

A team of Danish as well as Dutch researchers has gone on to combine an AI diagnostic tool along with a mammographic texture model so as to improve the evaluation when it comes to short- and long-term breast cancer risk. This novel approach goes on to represent a prominent step forward when it comes to refining the capacity to go ahead and also forecast the complexities pertaining to the breast cancer risk.

It is worth noting that one in every ten women is going to develop breast cancer at some given point in their life. The fact is that it happens to be the most common cancer in women, and goes on to get diagnosed mostly in the patients over the age of 50 years. At present, screening programs make use of mammography as their primary diagnostic tool when it comes to detecting the issue pertaining to breast cancer, and that too at an early stage, however, some lesions still go on to become quite challenging for radiologists to make sure to identify. Especially 55% of the cases happened to be accompanied by the presence of microcalcifications, which are tiny spots of calcium deposits, not over 0.1 mm in size, localized or even broadly diffused within the breast area. These calcifications happen to be frequently associated with premalignant as well as malignant lesions. In the present scenario, the majority in terms of breast cancer screening programs go on to base a woman’s estimated lifetime risk in terms of developing breast cancer on similar standard protocols.

Artificial Intelligence- AI, apparently, can be made use of for the purpose of diagnosing breast cancer earlier by way of automatically detecting the breast cancers in the mammograms and also measuring the risk which is involved in terms of future breast cancer, opined Dr. Andreas D. Lauritzen, who is a PhD, from the Department of Computer Science, University of Copenhagen. His team happened to partner along with the researchers from the Department of Radiology and Nuclear Medicine at Nijmegen’s Radboud University in the Netherlands on a project to blend two kinds of AI tools in order to leverage the respective strengths of both approaches, i.e., diagnostic models to go ahead and estimate short-term breast cancer risk as well as mammographic texture AI models to pinpoint the breast density, which happens to be an important marker when it comes to evaluating the long-term risk.

A retrospective study pertaining to the Danish women

It is well to be noted that the team of seven researchers from Denmark as well as the Netherlands looked forward to identifying whether commercially available diagnostic AI tools as well as an AI texture model, trained separately and then subsequently mixed, could go ahead and improve breast cancer risk evaluation. They made use of the diagnostic AI system Transpara, version 1.7.0, coming from a Nijmegen-based company named Screenpoint Medical B.V., and the texture model consisting of the deep learning encoder SE-ResNet 18, release 1.0, which they happened to develop themselves. Opined one of the authors of the study, Dr. My C. von Euler-Chelpin, an associate professor at the Centre for Epidemiology and Screening, Institute of Public Health, University of Copenhagen, said that a Dutch training set of more than 39,245 exams was made use of to train the deep learning models. The short- and long-term risk models happened to be combined by way of using a three-layer neural network. The mixed AI model happened to be tested on a study group of more than 119,650 women who happened to be included in a breast cancer screening program within the Capital Region of Denmark all throughout a three-year period from November 2012 to December 2015, with a minimum of five years of follow-up data. Apparently, the average age of the women happened to be 59 years.

Major interpretations show benefits

As per the results of their study, which got published in Radiology, the combination model went ahead and achieved a higher area under the curve- AUC as compared to the diagnostic AI or texture risk models separately in the case of the cancers diagnosed in two years of screening—interval cancers and those diagnosed post-this period—long-term cancers combined together.

The blended AI model also goes on to make it possible to go ahead and also identify women at high risk when it comes to breast cancer, with women identified as having the 10% highest combined risk, thereby comprising 44.1% of interval cancers as well as 33.7% of long-term cancers. According to Dr. Lauritzen and his colleagues, the findings indicated that mammography-based breast cancer risk evaluation is enhanced when blending an AI system for lesion detection as well as a mammographic texture model. Making use of AI to identify a woman’s breast cancer risk due to a single mammogram will not just result in earlier cancer detection but, at the same time, will also help alleviate strain on the healthcare system because of the worldwide shortage when it comes to specialist breast radiologists.

A fast and single mammogram approach having no clinic overheads

The present state-of-the-art clinical risk models go on to require multiple tests like blood work, mammograms, and genetic testing, as well as filling out extensive questionnaires, all of which would go on to substantially raise the workload within the screening clinic. Using their model, risk can go on to be evaluated by way of the same performance as the clinical risk models, however, within seconds of screening and even without introducing the overhead in the clinic, said Dr. Lauritzen in one of the press releases.

The fact is that the Danish-Dutch research team is now going to focus in terms of investigating the combination model architecture as well as further determining if the model adapts sufficiently to certain other mammographic devices along with institutions. The team went on to conclude that there has to be additional research which, apparently has to go ahead and focus in terms of translating combined risk to lifetime risk or even absolute risk for comparison when it comes to the traditional models.

Over 20mn People Dropped From Medicaid Amid Redeterminations

Throughout 2023, over 20 million Medicaid beneficiaries in the US have disenrolled from the safety-net insurance program as the states started to resume checking eligibility for coverage after a pandemic-era pause.

In total, 31% of people having a completed redetermination got disenrolled from Medicaid as of April 11, as per KFF, a tracker by a health policy research firm. 69%, or, one can say, above a million people, got their coverage renewed.

It is well to be noted that many people who got eliminated from Medicaid have not found other coverage yet. Almost a quarter of adults who happened to be disenrolled since early 2023 report at present being uninsured, as per the KFF survey.

During the COVID-19 pandemic, enrolment within the Medicaid saw a hike due to the Families First Coronavirus Act, which happened to provide increased federal funds for states as long as they went on to agree to not eliminate the beneficiaries from the coverage during the public health emergency.

However, that period pertaining to continuous enrolment ended almost a year ago, and states have since then been gauging who is still eligible when it comes to the safety net program.

The fact is that this process has been confusing for certain Medicaid enrolees, as per the research. Almost two-thirds were not sure if the states could eliminate the beneficiaries from the program if they did not happen to meet eligibility needs, according to a survey published shortly post unwinding began in 2023.

Apparently, there has also been quite a significant variation throughout the states when it comes to redeterminations, and there are numerous people who have been disenrolled due to procedural reasons, says KFF. In states having available data, 69% happened to have their coverage terminated due to the fact that they did not complete the renewal process, which, by the way, could mean that they are still eligible.

Notably, as the unwinding continued in 2023, regulators stepped in to go ahead and stem the tide of procedural disenrollments. That could happen due to the fact that the beneficiaries did not understand the process or because the state went ahead and listed outdated contact information.

Regulators also went on to pause the disenrollments in some states and, at the same time, issued an order in 2023 fall that specifically aimed to safeguard the children from being inappropriately disenrolled because of a system issue with automatic renewals.

Children comprised 37% of disenrollments across the 14 states that reported age breakdowns, says the latest KFF update. Interestingly, Texas happens to have a disproportionate impact on the number of children who have disenrolled because of its large size. The children’s share of Medicaid was recorded at 65% in the state, as compared to 20% which was seen in Oregon.

Is Azelaic Acid 14% Too Strong? Let the Dermatologists Weigh In

When you’re deciding which products to use in your skincare routine, you probably notice the wide range of concentrations listed on bottles and packaging. With azelaic acid, over-the-counter products typically contain 10% or less of the active ingredient. So is azelaic acid 14% too strong or just the right amount? Here’s what dermatologists have to say.

Evaluate Your Skin Type & Treatment Goals

After conducting studies on skincare products containing 10%, 14%, and 20% azelaic acid, researchers found that all three concentrations effectively treat acne. However, 10% azelaic acid products are not as effective at treating hyperpigmentation, lightening acne scars, and improving skin texture. Additionally, the lower concentration of azelaic acid is best for people with mild to moderate acne, but if you have more severe acne, you will see better results with a stronger product.

Products that contain 15-20% azelaic acid are only available with a prescription. Researchers also noted that some people using 20% azelaic acid experienced dryness and skin irritation due to the high concentration. So if you have sensitive or dry skin, you may experience these issues when using products with 20% azelaic acid.

So why 14% azelaic acid? Increasing the concentration of azelaic acid is the best way to make it more effective at treating skin conditions such as rosacea and hyperpigmentation. You can get products with 14% azelaic acid without a prescription, and this concentration also minimizes side effects such as stinging, drying, and redness. When you use a product with 14% azelaic acid, you will likely see the benefits within two to three months.

Azelaic Acid vs Benzoyl Peroxide

Benzoyl peroxide is commonly used to treat skin conditions, and you may wonder how azelaic acid for acne compares. Researchers have found that azelaic acid is just as good at clearing up acne as benzoyl peroxide. Both ingredients fight bacteria, which helps minimize new acne flare-ups. Benzoyl peroxide and azelaic acid are also effective at exfoliating skin and relieving inflammation.

Despite these similarities, there are key differences you should be aware of. Benzoyl peroxide makes your skin more sensitive to the sun and can damage your skin if you use it for a long time. It can also make your skin peel because it is a strong exfoliating ingredient.

Azelaic acid is comparably much more gentle than benzoyl peroxide. It doesn’t make you more prone to sunburn and won’t cause excess dryness and peeling. If you have sensitive or dry skin and acne, rosacea, or hyperpigmentation, azelaic acid is a good alternative to benzoyl peroxide.

How To Start Using Azelaic Acid 14% Cream

Use azelaic acid cream as the final step in your skincare routine but before sunscreen. Apply a pea-sized amount over your entire face once or twice a day. For the first few weeks, use the product every other day to avoid irritation.

Always protect your skin with a product that contains at least SPF 30. Retinol, BHAs, AHAs, glycolic acid, and lactic acid do not pair well with azelaic acid, but you should continue to use supporting ingredients such as hyaluronic acid, ceramides, and niacinamide.

You deserve to feel comfortable and confident in your skin. Explore the top supplements for pigmentation to address your concerns and embrace your complexion today.

AI Can Offer Decision Making Support In Heart Transplant

Researchers at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation- ISHLT held in Prague, say that artificial intelligence will go on to significantly impact the heart transplantation process by way of helping physicians better evaluate the complex factors that go on to impact patient outcomes.

According to the medical director of the Heart Transplant Program at the Cleveland Clinic, Eileen Hsich, up until now, they have assessed the likelihood of transplant success, which is based on individual risk factors, and that she thinks their guidelines will alter because they will be able to look at a mix of weighted risk factors and how they go on to interplay.

The fact is that work cannot be done manually. Machine learning can go on to provide data they have never had before, and it is indeed going to make a big difference.

MD, PhD, and senior consultant cardiothoracic surgeon, Johan Nilsson, at Skane University Hospital, who is also a professor at Lund University in Lund, Sweden, happen to be developing a decision-support tool, especially for transplant surgeons, that makes use of a modelling technique known as digital twinning. This kind of technique helps them to create a digital picture of every recipient, which can in turn help physicians forecast future patient outcomes based on specific combinations of data.

It is well to be noted that Dr. Nilsson’s team has gone on to build a database with multiple data points, such as clinical information as well as test results, on the overall 600 heart recipients and donors treated within his institution since the start of its transplantation program. They also happen to be in the process of sequencing the entire genome of recipients and their respective donors so as to add to the database. He said that the patients who are added to an organ transplant waiting list go on to offer a lot of health data as well as laboratory samples. The very same information is also gathered by the donor.

Dr. Nilsson happens to have plans to go ahead and also follow heart recipients after their procedure is done, thereby adding information like heart rate, blood oxygen levels, and biopsy results to the database. The benefits of algorithms are that they happen to provide a decision-support system that is unbiased and that can help physicians determine the 3 R’s which are the right donor at the right time and with the right patient. He adds that if one happens to get a donor in the middle of the night and there are three potential recipients, AI can go on to offer an independent system so as to help evaluate the best match.

As per Dr. Nilsson, AI can enable the improvement of organ allocation systems by way of helping physicians predict outcomes better at each and every step of the transplantation process.

A 2.6% Payment Hike For Inpatient Hospitals: CMS Suggests

The Biden administration is looking forward to hiking Medicare payments when it comes to inpatient care at hospitals by 2.6% in 2025, as per a rule that’s proposed on April 10.

The fact is that it is the lowest proposed rate ever since 2019, and that too below both the 2.8% surge in the CMS proposed for 2024 as well as the 3.1% hike that the regulators eventually finalized, as per Gary Taylor, the TD Cowen analyst. The fact is that it should still raise hospital payments by $3.2 billion, said the CMS.

Apparently, the hospital groups in the US decried the surge in the rate as insufficient in order to cover the rising costs when it comes to delivering care and went on to take issue with policies that could as well lower payments for the long-term care facilities.

It is well to be noted that the proposed payment rate happens to reflect a 3% surge to the market basket, which is an index that is meant to go ahead and also quantify changes in the prices of hospital goods as well as services, that got reduced by a 0.4% productivity adjustment.

Still, rates can as well increase in the final rule, which comes in August 2024. Historically, regulators have raised the rates after stakeholder’s lodge complaints pertaining to the proposal throughout the public comment period. Industry groups happen to be already lobbying for the CMS in order to hike payments, with the argument that the proposal is indeed not enough to enable the hospitals to function amid persistent inflation as well as labor costs.

The 2.6% update is indeed woefully not adequate, specifically following the years of high inflation along with the rising costs for labor, drugs and even equipment, remarks Ashley Thompson, senior vice president, public policy analysis and development at American Hospital Association.

It happens to be a perennial argument that hospitals make use of when vying for higher reimbursement from the government, and one that goes on to hold true for a number of small as well as rural hospitals. But there are major hospital operators that have notched high profit margins in recent years, and that too even during the pandemic, thanks to the generous federal aid as well as the more recent ones from the returning patient volume along with some strong investment returns.

Calvin Sternick, one of the J.P. Morgan analysts, said in an April 10 note that though the increase happens to be quite lower compared to recent years, they would note that the 2025 rate still happens to sit towards the higher end of historical rate surges, which generally go on to range between 1% and 3%.

In the past few years, pricing growth when it comes to hospitals has indeed lagged behind the elevated levels in terms of wage inflation, since the hospitals jockeyed for employees in a labor market that remained quite tight. Yet, industry-wide hospital wages have indeed fallen throughout the past year, as per Brian Tanquilut, one of Jefferies’ analysts.

As such, the rule happens to be laying a solid foundation when it comes to hospitals going ahead and maintaining margins given that wage inflation happens to be tracking in a similar range, said Tanquilut in a note.

In total, the for-profit facilities are all set to receive a 2.6% payment update in 2025 if the rule happens to be finalized as proposed. Nonprofit hospitals will go on to get a 2.3% bump.

Hospital groups were also up in arms pertaining to the payment changes in terms of long-term care hospitals that care for complex patients who require extended stays.

The CMS went on to propose a 2.8% rise to the standard federal payment rate for such kind of facilities. But the payments to long-term care hospitals were expected to rise 1.6%, or $41 million, post-adjusting for a forecasted decrease in high-cost outlier payments in 2025.

Regulators went ahead and even proposed increasing the long-term care hospital outlier threshold by an extraordinary amount, Thompson from the AHA said. The outlier threshold happens to be how much the costs of treating a patient must exceed hospital payments in order to qualify for additional reimbursement.

The changes would go on to result in an extra $31,048 loss per patient for facilities, exacerbating functional concerns for the hospitals and also putting more pressure on short-term acute care facilities as well as their intensive care units, said Thompson.

Payments so as to disproportionately share hospitals that go ahead and serve high numbers of low-income patients would see a surge of $560 million when it comes to the proposed rule.

This is as much as a drop of $957 million for 2024, after the regulators go on to forecast that the uninsured rate would see a dip due to pandemic-era coverage gains, in spite of the Medicaid redeterminations throwing millions of Americans off the coverage.

It is well to be noted that the CMS also went ahead and proposed hospitals create a permanent data reporting structure in terms of COVID-19 as well as other respiratory viruses such as flu and RSV. The dearth of a standardized process hamstrung the public health agencies’ capacity to get a handle on COVID-19 in the pandemic’s early days.

The rule in a way would also require long-term care facilities to go ahead and report social determinants pertaining to health data, such as housing and food stability, so as to account for the resources needed to care for homeless individuals. It would as well increase technology payments to go ahead and help enhance access to gene therapy when it comes to sickle cell disease, and also create a varied payment to small independent hospitals so as to create a buffer stock of necessary medicines.

US Legislators Talk Telehealth Cost, Quality As Cutoff Nears

Lawmakers in the US have gone on to laud the advantages of telehealth in a hearing held on April 10, but House members also went ahead and raised questions pertaining to cost, quality, as well as the access that still have to be answered as a year-end deadline looms.

The fact is that as the December 2024 deadline draws closer, legislators happen to be working to hash out details pertaining to extending or even making pandemic-era telehealth flexibilities within Medicare permanent.

In an hours-long House Energy and Commerce subcommittee hearing, lawmakers went on to consider 15 different legislative proposals that happened to surround telehealth access, noting changes within Medicare will go on to impact decisions pertaining to private insurers.

Rep. Anna Eshoo said there is indeed an urgent requirement so as to extend these flexibilities because they are indeed going to run out and certainly need to take action on this.

It is well to be noted that during a public health emergency, regulators loosened some of the telehealth rules, such as allowing beneficiaries to go ahead and receive virtual care in their homes, eradicating the geographic restrictions, and expanding the audio-only telehealth services.

While there are some changes which have been made permanent, others are due to expire at the end of 2024, which could as well spell a crisis for providers as well as patients who are used to flexibilities, the witnesses at the hearing told the lawmakers.

The fact is that some policy questions that surround telehealth still linger, such as how to make sure of quality care and continuing access to in-person services and how much to pay providers when it comes to telehealth.

As per Rep. Brett Guthrie, the looming deadline goes on to give a chance to assess the long-term telehealth solutions, that can indeed drive innovation within the healthcare gamut by way of greater delivery.

The question now is: how much does Medicare go on to pay for telehealth?

It is worth noting that telehealth does surge healthcare spending modestly, but it is also linked to enhancements in access as well as care quality, said professor of healthcare policy and medicine, Harvard Medical School, Ateev Mehrotra.

However, the providers have to be paid less when it comes to the virtual services, he added. Medicare payments have to be based on the time it takes to go ahead and offer care and the associated space, staff, and equipment, so the fact remains that virtual care should cost less and should be reimbursed at lower levels.

In addition to this, the payment parity with in-person services can also encourage providers to go ahead and give up their physician practices, or even offer an unfair advantage to telehealth companies that only provide virtual care.

Still, the fact remains that providing telehealth does not mean other overhead costs happen to go away, said group vice president as well as the chief of virtual care and digital health, health system Providence, Eve Cunningham, and apparently, it does take resources to set up as well as manage a virtual care program.

Underpaying could go on to create the wrong incentives as well, opines Rep. Larry Bucshon.

He adds that one really cannot pay substantially less when it comes to telehealth services. There has to be a balance in it, because that will, in a way, discourage providers from giving them at all.

Questions pertaining to quality

Lawmakers, notably, also went ahead and raised questions pertaining to what types of care are best suited when it comes to telehealth services.

Rep. Kim Schrier says that as a community pediatrician, what is needed is a height, a weight, and a growth chart. There is a need for blood pressures too, as well as that pre-work before one walk into the office. What Kim goes on to evaluate is how many diagnoses have actually got missed since one did not see curve in the back, a mole on the skin, or falling off when it comes to a growth curve?

Apparently, when the patients returned to physician’s offices after the pandemic eased, providers may have gauged new symptoms after getting a physical exam done, said the senior vice president and chief digital health officer with Yale New Haven Health System, Lee Schwamm. However, many people simply are not able to access care at all, which is indeed an area where telehealth could go ahead and help.

He adds that they might have missed some things, but in comparison to what? Probably in comparison to perfect in-person care, sure. However, in comparison to reality, he thinks they are more likely to pick up signs as well as symptoms because they happen to be actually interacting with the person.

Another quality concern happens to be the care offered by telehealth-only companies, said Mehrotra from Harvard. In a written testimony, he cited one of the startups and a mental healthcare provider, Cerebral, which was accused of going ahead and overprescribing prescription stimulants, thereby arguing on the fact that there was a shortage of data on telehealth-only companies’ effect when it came to quality.

Preserving access to in-person care

Interestingly, Medicare beneficiaries also need to be able to access the in-person options if they go on to prefer, witnesses as well as lawmakers said.

To make sure of an in-person access for beneficiaries, telehealth providers should not be enabled to go ahead and meet network adequacy rules for the Medicare Advantage plans, said President of the nonprofit Medicare Rights Center, Fred Riccardi. Now that there are more than half of the eligible beneficiaries who are enrolled in the private MA plans, telehealth companies should not be able to meet those standards and, at the same time, inadvertently erode in-person access, he said.

As per Rep. Frank Pallone, it is indeed important that one goes on to preserve patient choice and that Medicare beneficiaries continue to have access to high-quality in-person care as well as robust consumer protections, such as network adequacy standards.

The fact is that Congress needs to take that action soon in order to reduce uncertainty for providers, the witnesses said.

Patients go on to anticipate this model of care now, and the providers have to have a permanent solution so as to justify the funds required in order to support telehealth, Cunningham from Providence said.

She remarked that when there is uncertainty in the reimbursement model and they happen to be kicking the can down the road in one year, the next year, there happens to be a hesitancy, specifically from these smaller practices, so as to really go all-in as there is an investment involved in making that kind of transition. The fact is that they need to have that sort of reassurance that reimbursement will be stable.

1...124125126...1,134Page 125 of 1,134

About us

Hospital & healthcare Management is a leading B2B arena designed for the healthcare sector, it allow members to reach both ends of the healthcare facility procurement chain. . . Read More

Subscribe us

System

Resources

Archive Links

Subscribe

Copyright © 2008 - 2026 Hospital & Healthcare Management. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »